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Abstract
Backgound: Y-chromosomal microdeletions (YCMD) are one of the major genetic causes for non-obstructive azoospermia.
Genetic testing for YCMD by multiplex polymerase chain reaction (PCR) is an established method for quick and robust
screening of deletions in the AZF regions of the Y-chromosome. Multiplex PCRs have the advantage of including a control
gene in every reaction and significantly reducing the number of reactions needed to screen the relevant genomic markers.
Principal Findings: The widely established ‘‘EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal
microdeletions (2004)’’ were used as a basis for designing a real-time multiplex PCR system, in which the YCMD can simply
be identified by their melting points. For this reason, some AZF primers were substituted by primers for regions in their
genomic proximity, and the ZFX/ZFY control primer was exchanged by the AMELX/AMELY control primer. Furthermore, we
substituted the classical SybrGreen I dye by the novel and high-performing DNA-binding dye EvaGreen
TM and put
substantial effort in titrating the primer combinations in respect to optimal melting peak separation and peak size.
Significance: With these changes, we were able to develop a platform-independent and robust real-time based multiplex
PCR, which makes the need for amplicon identification by electrophoretic sizing expendable. By using an open-source
system for real-time PCR analysis, we further demonstrate the applicability of automated melting point and YCMD
detection.
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Introduction
In Western countries, infertility is a major health problem that
affects about 15% of couples trying to conceive [1]. Y-chromosomal
microdeletions (YCMD), along with Klinefelter syndrome, are the
major genetic cause for primary spermatogenic failure on the male
side, accounting for 5–10% of all non-obstructive azoospermic
men [2].
Three regions, commonly referred to as ‘‘azoospermia factors’’
(AZFa, AZFb and AZFc) have been defined as spermatogenic loci
and are recurrently deleted in YCMD [3], distributing among
60% (AZFc), 16% (AZFb) and 14% (AZFb+c), albeit with signi-
ficant bias in different populations [4,5]. The testicular phenotype
in men bearing YCMD depends on the type of deletion, ranging
from Sertoli cell-only syndrome (SCO) in AZFa [6,7], SCO to
meiotic arrest in cases of complete AZFb/AZFb+c deletions [2],
up to the very heterogeneous pattern from hypospermatogenesis to
SCO in AZFc deletions [8,9].
To date, there are no defined criteria as to when patients should
undergo YCMD genetic testing. An obvious target are patients
subjected to intracytoplasmic sperm injection (ICSI) treatment
which present with severe oligozoospermia (,1610
6/mL) [10].
Identification of YCMD prior to ICSI treatment can predict their
transmission to offspring, as these are inevitably herited [11].
Furthermore, the extent of YCMD in a patient might be
prognostic for finding spermatozoa in testicular biopsies [12].
There are also strong indications that an increased frequency of
nullisomic sperm in the ejaculate of men with AZFc deletions
might raise the potential risk of 45,X Turner’s syndrome [13].
Consequently, genetic testing of YCMD would optimally be a
routine diagnostic for the andrological laboratory, with emphasis
on being relatively affordable for the consulting couple and
delivering fast results for initial decision making. These demands
have been solved by the development of multiplex polymerase
chain reactions (PCR) using combinations of primers to simulta-
neously amplify sequence-tagged sites (STS) within the three
genomic AZF regions, usually in combination with a non-deleted
Y-chromosomal control gene such as sex-determining region Y
(SRY) or amelogenin Y (AMELY). In the last years, a plethora of
protocols have been developed that vary significantly in the use of
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A compendium of established protocols is given in Table 1. Since
the complete mapping of the male-specific region of the Y-
chromosome (MSY) [14], many different STS-specific primers
have been employed in the various protocols, enabling the
detection of more detailed rearrangements in the palindromic/
ampliconic regions of the MSY. However, for a relatively quick
and versatile multiplex PCR-based YCMD detection method, it is
important that the panel of STS primers is derived from regions of
the MSY that are not polymorphic and that correlate well with
their absence in men affected by oligo/azoospermia.
In this work we aimed to develop a multiplex PCR protocol which
eliminates the need for downstream amplicon identification, such as
agarose gel or capillary electrophoresis. On the basis of classical STS
primers that cover 95% of all clinical relevant deletions reported in
the literature as defined in the ‘‘EAA/EMQN guidelines for
molecular diagnosis of Y-chromosomal microdeletions (2004)’’ [10],
some of these primers were exchanged using sites in the genomic
proximity. Empirically, primers and multiplex primer combinations
were developed that result in a high separation of melting peaks
during the melting curve program after PCR amplification, enabling
in the presence of the new high-performance fluorescent dye
EvaGreen
TM the identification of all amplicons in a multiplex set
only by means of their Tm values, hence making amplicon and
deletion identification by amplicon size expendable.
Results
Validation of new AZF primer combinations
In an initial approach to develop a multiplex real-time PCR
system for YCMD that utilizes only amplicon melting curve
identification, we tested the classical Simoni et al. [10] multiplex
system for its performance. We were not able to establish a
functionate multiplex melting curve-based setup due to similarity
of some amplicons in their melting temperature within a window
of 0.5–1uC (i.e. ZFY, sY86, sY84 and sY255; see Materials &
Methods), resulting in a convolution of the melting peaks that
severely impeded the Tm identification of the amplicons. This
made it necessary to evaluate other primer combinations, with the
premise that substituting primers should be located in the genomic
proximity of the established Simoni et al. [10] primers in regions
that are not polymorphic and guarantee to identify over 95% of
the most common AZF deletions. Using SybrGreen I chemistry,
we tested over 30 different STS primers for the three different
AZF regions in combinations, using the peak separability of the
multiplex melting curve as the selection criterion. The classic
ZFX/ZFY control gene, present in male and female DNA, had to
be substituted by primers for AMELX/AMELY with 5uC less
melting temperature. This made it more suitable within the
framework of the remaining multiplex amplicons. The SRY control
gene for male DNA of the Simoni et al. [10] setup could be
included. The AZF-specific primers substituting the original ones
were sY85/G34990 (instead of sY86/sY84) for the AZFa region
and sY133 (instead of sY134) for the AZFb region. These primers
were combined with sY254 (AZFc), sY255 (AZFc) and sY127
(AZFb) from Simoni et al. [10] to establish two different 4-plex
setups as summarized in Table 2. High peak separability was
achieved by selecting combinations in which the Tm values ranged
from 77–87uC, with at least 2uC difference between each of the
products. We had attempted to develop a 5-plex setup as in the
original Simoni et al. [10] setup, but it was not possible to include
Table 1. Compilation of recent investigations employing single- and multiplex PCR for the detection of YCMD.
Reference Primers Multiplex Detection Real-time Dye
UMENO et al. [24] classical 6-plex Hitachi Microchip
AKNIN-SEIFER et al. [41] classical+kit 266-plex Agarose gel electrophoresis (?)
ZHANG et al. [22] selected 6-plex Agarose/Capillary electrophoresis SybrGreen I/FAM
LIN et al. [42] partial AZFc 6-plex Agarose gel electrophoresis
BOR et al. [43] classical 565-plex Agarose gel electrophoresis
THORNHILL et al. [44] classical 264-plex Agarose gel electrophoresis
BOR et al. [25] classical 565-plex Capillary electrophoresis FAM/HEX
MARTINEZ et al. [45] classical 363-plex Agarose gel electrophoresis
KLEIMAN et al. [46] selected for transcripts 4-, 3-, 1-plex Agarose gel electrophoresis
CHARPENEL et al. [26] classical 463-plex, 164-plex Agarose gel electrophoresis
KENT-FIRST et al. [47] classical+AZFd 964-8-plex Agarose gel electrophoresis
HENEGARIU et al. [48] classical+selected 7-, 5-, 7-, 5-, 5-plex Agarose gel electrophoresis
MITRA et al. [49] classical+selected 264-plex Agarose gel electrophoresis
PLASESKI et al. [21] selected 11-plex Capillary electrophoresis FAM/HEX
FODOR et al. [27] selected 5-plex Capillary electrophoresis
LIN et al. [42] classical+selected 6-plex Agarose gel electrophoresis
HUCKLENBROICH et al. [50] selected 3-, 2-plex Agarose gel electrophoresis
JABASINI et al. [51] selected for haplotyping 7-, 5-plex Hitachi Microchip
BUCH et al. [23] selected 1661-plex Melting curve SybrGreen I
Promega Corp., WI, USA YCMD
Detection Sytem 2.0 (2009)
proprietary 6-, 5-, 4-plex Agarose gel electrophoresis
Primers noted are either those of Simoni et al. [10] (‘‘classical’’) or specifically designed for the region to be amplified (‘‘selected’’). If quantitative real-time PCRs were
conducted, dye chemistry is noted under ‘Real-Time Dye’. All protocols but one (Buch et al. [23]) base their analysis on the electrophoretic separation of amplicons.
doi:10.1371/journal.pone.0023174.t001
Real-Time Multiplex PCR for YCMD
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decreasing peak separability.
A detailed genomic location map of the new primers is given in
Figure 1, with the primers employed in our two multiplex setups in
red and substituted primers from Simoni et al. [10] in black. The
numbers in brackets define their genomic locations based on the
GRCh37/hg19 assembly (Feb. 2009).
Increasing melting curve resolution by EvaGreen
TM
In principle, the two multiplex setups could be established using
SybrGreen I chemistry. However, in a further effort to increase
melting peak resolution, we tested two other DNA-binding dyes in
respect to signal strength and peak separability. Syto-13 had been
shown to be less inhibitory to PCR, show no preferential binding to
GC-rich sequences and to not influence melting temperature [15].
EvaGreen
TM exhibits similar features and is highly tolerable to PCR
enzymes even at high concentrations, permitting strong fluorescence
readouts during amplification and melting curve analysis [16].
We tested the two setups with each of these dyes and noticed an
extremely superior performance of EvaGreen
TM, giving very high
fluorescence signals during the amplification phase (data not
shown) and strong signals with prominent melting peaks during
the melting program, as shown with the AMELxy setup compared
to the two other dyes (Figure 2). Syto-13 displayed a very low
overall signal range, SybrGreen I performed better, with all (four)
peaks present, but EvaGreen
TM exhibited a signal range almost an
order of magnitude higher. Therefore, we selected EvaGreen
TM as
the appropriate DNA-binding dye for YCMD detection by real-
time multiplex PCR.
Performance of the two different 4-plex setups to detect
YCMD
We tested each of the two different multiplex setups on isolated
genomic DNA from a fertile man (positive control: PC), and men
bearing either an AZFa, AZFb+c or AZFc deletion. A non-
template control (water) served for contamination testing. The
results for the SRY and AMELxy multiplex setups are given in
Figures 3 and 4, respectively. Each of the corresponding melting
curves (black lines) exported from the PCR system was imported
into the ‘qpcR’ package. The function meltcurve was invoked which
conducts an automatic first derivative melting curve transforma-
tion (red lines) and peak identification, including calculation of the
respective Tm values. For each of the two setups, all investigated
AZF deletions could be clearly identified by the absence of the
corresponding peaks, as noted by asterisks in the single melting
graphs. The positive control gave four discriminable peaks in all
two setups, and the control amplicons (SRY: 86.74–87.08uC;
AMELxy: 79.88–79.97uC; see Table 2) were present as sharp
peaks in all positive controls or AZF melting curves. We verified
the amplicons that pertain to the individual melting peaks by
subsequent microcapillary electrophoresis (Bioanalyzer) and could
identify each of the amplicons by the corresponding present or
absent bands, depending on type of AZF deletion. All Tm values
(given as ranges) and amplicon sizes are summarized in Table 2.
Robustness and sensitivity analysis of the two multiplex
setups
To test the developed YCMD multiplex system for robustness in
respect to peak strength and separability, the two setups were
tested on four different genomic DNAs from men without AZF
deletions. Irrespective of genomic origin, the melting peaks from
all four samples could be clearly distinguished (Figure S1A). There
were small individual differences in peak height/area, but in all of
the samples, individual peaks were well separated. In addition,
microcapillary electrophoresis displayed a homogeneous pattern of
the corresponding amplicons (Figure S1B). The sensitivity of the
system was evaluated by using genomic DNA from a positive
control and conducting real-time PCR with subsequent melting
curve analysis on increasing two-fold dilutions (Figure S1C). The
Table 2. Primers used for the two different multiplex setups.
Setup 1 Primers
Concentration
[nM] Origin
Amplicon
Tm [6C]
Amplicon
Size [bp] Location [bp]
SRY (Control) GAATATTCCCGCTCTCCGGA/
GCTGGTGCTCCATTCTTGAG
125 Simoni
et al. [10]
86.50–86.68 470 2655107–2655576
sY254 (AZFc,
DAZ1-4)
GGGTGTTACCAGAAGGCAAA/
GAACCGTATCTACCAAAGCAGC
50 81.51–81.83 380 25316193–25316572; 25372576–25372955;
26952264–26952643; 26986963–26987342
sY133 (AZFb) ATTTCTCTGCCCTTCACCAG/
TGATGATTGCCTAAAGGGAA
500 NEW 83.86–84.11 177 23499309–23499485
sY85 (AZFa) GCTATTCTCTCTCTGGCATC-TGTATT/
TGGCAATTTGCCTAT- GAAGT
375 NEW 76.61–76.81 80 14638102–14638181
Setup 2
AMELxy
(Control)
ATCAGAGCTTAAACTGGG-AAGCTG/
CCCTGGGCTCTG-TAAAGAATAGTG
250 NEW 79.79–80.02 106 (X)
112 (Y)
11314994–11315099 (X);
6737888–6737999 (Y)
sY255 (AZFc,
DAZ1-4)
GTTACAGGATTCGGCGTGAT/
CTCGTCATGTGCAGCCAC
125 Simoni
et al. [10]
84.35–84.52 124 25314817–25314940; 25374208–25374331;
26950888–26951011; 26988595–26988718)
sY127 (AZFb) GGCTCACAAACGAAAAGAAA/
CTGCAGGCAGTAATAAGGGA
300 Simoni
et al. [10]
82.21–82.28 274 22570417–22570690
G34990 (AZFa) CATTCGGTTTTATCAGCCAG/
CAGTGACTCGAGGTTCAATG
750 NEW 76.41–76.56 83 15032211–15032293
Alternatively:
AMELy (Control)
ATCAGAGCT TAAACTGGG-AAGCTG/
CTCTGTAAAGAA- TAGTGGGTGGAT
500 NEW 79.33–79.56 105 6737888–6737992
Given are their sequences, the final concentration in the PCR reaction, the origin (either Simoni et al. [10] or newly designed), the amplicon melting temperatures (given
as regions), amplicon size and the Y-chromosomal location based on Human Genome GRCh37/hg19 assembly (Feb. 2009).
doi:10.1371/journal.pone.0023174.t002
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initial DNA concentration of 0.35 ng/ml after 40 cycles of
amplification.
A further establishment of robustness was conducted by using
18 new samples (11 controls, 6 AZFc and 1 AZFbc) for multiplex
setups performed by a different female co-worker (Figure S3, S4,
S5). With the exception of one reaction (Setup 3, Con_03), in all
investigated setups (Setup 1, Setup 2 and Setup 2 with alternative
AMELy primer, denoted as Setup 3) four clearly separable peaks
were visible for the control reactions. In agreement with the
corresponding deleted regions, AZFc and AZFbc samples
exhibited three or two peaks.
Test of AMELxy control primers and portability of the
multiplex setup to a 96-well block based system
In our developed multiplex system, the ZFX/ZFY control
primers which are male/female specific and test for contamination
with femal genomic DNA in the Simoni et al. [10] setup are
substituted by the AMELX/AMELY primer pair in multiplex
Setup 2 sharing the same features. However, in contrast to the
ZFX/ZFY primers which produce a 495 bp amplicon from the X-
and Y-chromosomal regions, AMELX/AMELY amplicons can be
distinguished by capillary electrophoretic sizing by means of their
6 bp size difference depending on X- or Y-chromosomal origin
(see double band at 106/112 bp in Figure 4). As an alternative,
multiplex Setup 2 containing an AMELY-specific primer (105 bp
amplicon) can be used if testing for female contamination is
considered superfluous (Table 2; see Discussion). We tested the
gender specificity of both primer pairs on female genomic DNA
from blood and verified the AMELxy primer to amplify the female
AMELX region, while the AMELy primer did not (Figure S2A).
As the multiplex system was established on a glass capillary-
based real-time PCR system (Lightcycler
TM), it was important to
prove general applicability by validating the performance on a 96-
well block based PCR system (Stratagene MX3000). The reaction
volume was extended from 20 mlt o2 5ml while keeping all primer
concentrations fixed at those in the initial setup (Table 2). For each
Figure 1. Y-chromosomal locations of the primers used for the two multiplex setups. Schematic representation of the Y-chromosome
similar to Simoni et al. [10] showing the positions of the multiplex primers for the detection of AZFa, AZFb and AZFc deletions. The models from Vogt
et al. [3] and Repping et al. [52] are shown on the left and right, respectively. The locations of the STS primers used for the two multiplex real-time
setups in this work are given in red together with their genomic positions based on the GRCh37/hg19 assembly (Feb. 2009).
doi:10.1371/journal.pone.0023174.g001
Real-Time Multiplex PCR for YCMD
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three individuals without AZF deletions, from men with AZFa/
AZFb+c/AZFc deletions and a non-template control (water).
Similar to our results obtained with the Lightcycler system, each of
the three control samples (Figure S2B+C, upper rows) exhibited 4
clearly identifiable and separable melting peaks. In the AZFa,
AZFb+c and AZFc deleted samples (Figure S2B+C, middle rows),
the corresponding peaks are missing and the non-template control
samples are all negative (Figure S2B+C, lower rows).
Discussion
The establishment of YCMDs as a major cause of impaired
spermatogenesis, triggered by the discovery of the DAZ gene [17]
and the description of three discrete AZF loci [3], has led to
increasing interest in the genomic analysis of male infertility. With
the popularization of the PCR (polymerase chain reaction)
methodology, rapid testing for the presence or absence of YCMD
by amplification of the respective AZF loci is achievable in matter
of a few hours. Although YCMD were initially screened by
singleplex PCRs on sequence-tagged sites of the AZF regions
[18,19,20], several multiplex PCR systems for YCMD detection
have recently been developed. The simultaneous amplification of
more than one AZF locus in the presence of control genes confers
robustness to the interpretation of the results by ensuring a
successful and sensitive amplification reaction. In light of possible
false negative results when the PCR reaction fails, this avoids
misinterpretations in respect to the patient’s fertility status.
In addition to the plethora of existing multiplex protocols that
are based on PCR amplification and subsequent analysis of the
amplicons by agarose gel/capillary electrophoresis, real-time PCR
approaches exist which monitor the multiplex amplification. We
have compiled existing multiplex systems for the identification of
YCMD in Table 1. Using real-time PCR offers the possibility of
detecting initial cross-contamination, avoiding prolonged amplifi-
cation in the saturation phase of the PCR, identifying low quality
DNA (by high crossing points) and quantifying ratios of AZF genes
or their copy numbers [21,22]. In all established protocols, post-
PCR amplicon separation by either agarose gel or capillary
electrophoresis is employed to identify the presence or absence of
an AZF deletion (see Table 1, ‘Detection’). We are only aware of
one work in which the YCMD identification is based solely on
singleplex amplicon detection by melting curve analysis [23] (see
Table 1). This is an interesting approach, as the presence/absence
of YCMD can be checked by the absence/presence of the
corresponding amplicons, and the validity of the amplicons is
quickly verified by the typical melting point (Tm) of the PCR
product. The major advantage, however, is that any following
identification of the amplicons by electrophoretic size separation is
made expendable, hence saving considerate time and investment.
Since a multiplex setup has several advantages over singleplex
methods, such as reducing the number of reactions/input DNA
and inclusion of an internal control gene for the monitoring of
successful amplification, we aimed to develop a real-time based
multiplex approach based only on melting curve amplicon
identification. Furthermore, the method should be robust,
sensitive, portable between different PCR hardwares (with little
optimization needed) and give rise to automatic amplicon
detection.
Similar to other investigations [23–26], and because there are
no specific rules governing the STS marker selection, we initially
chose to select the classical multiplex primer setup from Simoni
Figure 2. Testing three different DNA-binding fluorescent dyes for multiplex performance. EvaGreen (blue), SybrGreen (green) and Syto-
13 (red) were tested for peak amplitude and peak separability using the AMELxy multiplex setup. Highest performance in respect to these two criteria
was obtained with the EvaGreen dye, as can be seen by the 3–20 times higher melting peaks of the individual amplicons within the multiplex
reaction compared to classical SybrGreen. NTC: baseline fluorescence of EvaGreen without DNA template.
doi:10.1371/journal.pone.0023174.g002
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reported. As is widely established, it was possible to conduct a
multiplex PCR with this setup and identify the amplicons by
electrophoretic separation. However, due to the high similarity in
the Tm values of ZFY, sY86, sY84 and sY255 (85.2uC, 86.1uC,
86.0uC, 84.7uC, respectively), an identification only by analysis of
the melting peaks was not possible due to peak convolution. The
substitution of the ZFX/ZFY control gene with the corresponding
AMELX/AMELY control gene as in [27], sY86/sY84 by sY85/
G34990 (AZFa), and sY134 by sY133 (AZFb), provided the basis
for two different 4-plex setups in which the amplicon peaks
displayed 2uC separability (see Table 2). The genomic proximity of
the substituting primers for the AZFa and AZFb region ensures a
similar outcome to the Simoni et al. [10] setup, as they are located
within the same breakpoints [28–30]. However, it was not possible
to include two control primer pairs in each multiplex reaction,
such as ZFX/ZFY and SRY in Simoni et al. [10], because peak
separability could not be maintained in the case of a 5-plex setup.
We therefore split the multiplexes into two different 4-plex setups
with SRY (male specific) and AMELxy (male/female-specific),
using one control in each multiplex. With these two setups,
the following scenarios can be identified: (i) Contamination
with female DNA would give an increase in the 106 bp X-
chromosomal derived amplicon. This is not clearly distinguishable,
but the same accounts for the original Simoni et al. [10] setup. (ii)
Accidentally using female DNA would give a negative SRY setup,
and a positive AMELxy setup without AZF-specific signals. In this
unlikely case, absence of male genomic DNA could be verified
further by absence of the AMELy amplicon, which can be used as
an alternative in Setup 2 (Table 2). (iii) In the rare case of an XX-
male, the SRY control from Setup 1 should be positive, although
recent results show that XX-males might even be negative for this
gene [31]. (iv) In case of an AMELy deletion, encountered
infrequently in the Asian population [32], the AMELx amplicon
would serve as an internal control for a successful amplification.
The decision to exchange the commonly used SybrGreen I dye
by the relatively new EvaGreen
TM dye was based on the known
poor performance of SybrGreen I in melting curve analysis
[33,34] and our own observation that EvaGreen
TM delivered
much higher fluorescence values during amplification and strong
peaks during melting curve analysis. We then put considerable
effort in titrating the primers with the goal of obtaining fairly equal
amounts of the individual amplicons [35], an essential prerequisite
for robust peak identification.
With this developed multiplex system, we were able to
accurately identify the missing amplicons as a consequence of
Figure 3. Multiplex Setup 1 (SRY). The SRY multiplex setup was tested on genomic DNA from patients without deletions (PC), AZFa deletion
(AZFa), AZFb+c deletion (AZFbc), AZFc deletion (AZFc) and on a non-template control (NC). Black curves represent the original melt curve (scaled on
left ordinate), while the red curves represent the first derivative melt curve (scaled on right ordinate). Asterisks denote missing peaks in comparison to
the positive control. The abscissas reflect temperature [uC], ordinates reflect relative fluorescence [AU]. Bottom right: Microelectrophoretic separation
(Bioanalyzer) of the amplicons obtained with the different setups as above (M=size marker).
doi:10.1371/journal.pone.0023174.g003
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and AZFc deletions. The identification of the YCMD was robust,
sensitive and independent of PCR hardware. For the safe-minded,
and as shown by the microelectrophoretic separations of the
multiplex PCRs in this work, it is possible for an initial validation
(i.e. when setting up this system in a laboratory) to correlate and
validate the melting peaks from the PCR machine with the
electrophoretic sizing of the amplicons. But we want to emphasize
that this is only necessary once, as the Tm values alone suffice.
Furthermore, by using the ‘qpcR’ package for the open-source
statistical environment R, we show in this work the potential for
automatic peak identification of the multiplex melting curves,
including Tm calculation.
In recent years, other genetic alterations have been identified
which are involved in male infertility, such as Y-chromosomal
haplogroups that are associated with reduced fertility [36], partial
deletions in the AZFc region [37] or point-mutations in AZF
located genes [38]. One drawback of our multiplex system, which
is restricted by the number of amplicons whose melting peaks can
be clearly distinguished, is that it can only identify larger deletions,
as in the well established Simoni et al. [10] protocol.
We believe that our method is a great improvement to existing
multiplex PCR methods for the detection of YCMD, since it is the
first real-time based multiplex approach in this field, with all
advantages of the latter such as amplification monitoring, an
internal control in each reaction, decreased PCR setup number
and most importantly, the elimination of any downstream
amplicon analysis such as gel/capillary electrophoresis. A potential
automation of Tm and hence YCMD identification, as exemplified
in this work, may increase the benefit of this system even further.
Materials and Methods
Isolation of genomic DNA
Genomic DNA from control (n=5), AZFa (n=1), AZFbc
(n=4) and AZFc (n=7) samples was isolated from testicular tissue
obtained from a therapeutic testicular sperm extraction procedure
(TESE), after direct surgical immersion of a rice grain sized biopsy
sample in 2 ml RNAlaterH (Ambion, Austin, TX), using the
DNeasy Tissue Kit (Qiagen, Hilden, Germany). A second set of
control (n=11), AZFc (n=6) and AZFbc (n=1) samples was
additionally investigated by a different female scientist to test
against individual bias. Written informed consent and approval
was obtained from the Ethical Commision of the Medical Board
Hamburg (Approval OB/X/2000), and the studies conducted in
accordance with the guidelines of the Helsinki Declaration regarding
Figure 4. Multiplex Setup 2 (AMELxy). The AMELxy multiplex setup was tested on genomic DNA from patients without deletions (PC), AZFa
deletion (AZFa), AZFb+c deletion (AZFbc), AZFc deletion (AZFc) and on a non-template control (NC). Black curves represent the original melt curve
(scaled on left ordinate), while the red curves represent the first derivative melt curve (scaled on right ordinate). Asterisks denote missing peaks in
comparison to the positive control. The abscissas reflect temperature [uC], ordinates reflect relative fluorescence [AU]. Bottom right:
Microelectrophoretic separation (Bioanalyzer) of the amplicons obtained with the different setups as above (M=size marker).
doi:10.1371/journal.pone.0023174.g004
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[39]. DNA purity (ratio 260 nm/280 nm) was assessed on an
Ultrospec 3000 spectrophotometer (GE Healthcare, Freiburg
Germany). Genomic DNA integrity was checked by 1%
agarose/TAE gelelectrophoresis. Female DNA from blood was
obtained with the DNeasy Tissue Kit (Qiagen) according to the
manufacturer’s protocol. Genomic DNA from a male with an
AZFa deletion was isolated from blood with the FlexiGene DNA
Kit (Qiagen).
Selection of suitable multiplex primers for the detection
of YCMD
From an empirical (by quantitative PCR) validation of over 30
primer pairs deposited in the NCBI UniSTS database (http://
www.ncbi.nlm.nih.gov/unists/), we selected primer combinations
which resemble a similar setup as in the widely established Simoni
et al. protocol [10]. However, the classical setup is only applicable
when subsequent amplicon size analysis by gel electrophoresis is
conducted. The amplicons can not be discriminated by melting
curve analysis alone as their Tm values differ only in a region of
0.5–1uC. This was especially the case for primers specific to ZFY
(control gene, Tm=85.2uC), sY86 (AZFa, Tm=86.1uC), sY84
(AZFa, Tm=86.0uC) and sY255 (AZFc, Tm=84.7uC) whose
combined amplicons lacked separability in melting curve analysis.
Using the NCBI UniSTS database, alternative primers were
selected for genomic sites in near proximity to the original primers.
These were validated through quantitative PCR by combining
them with any of the remaining primers to establish maximal
separability of the melting curve peaks (Tm values). Primer
sequences were rechecked for sequence specificity by NCBI
BLAST (http://blast.ncbi.nlm.nih.gov/) and UCSC Genome
ePCR (http://genome.ucsc.edu/cgi-bin/hgPcr?command=start).
Validated substitutes for the primers above which displayed high
separability in their Tm values were AMELxy (control), sY85
(AZFa), G34990 (AZFa), and sY133 (AZFb). These primers were
combined with the remaining primers sY254 (AZFc), sY255
(AZFc) and sY127 (AZFb) from Simoni et al. [10] to establish two
different 4-plex setups as summarized in Table 2.
Quantitative real-time PCR (qPCR) setup and parameters
The two different multiplex setups were tested with three
different DNA-binding dyes (SybrGreen I, Invitrogen, Darmstadt,
Germany; Syto-13, Invitrogen, Darmstadt, Germany; Eva-
Green
TM, Biotium, Hayward, USA) in order to investigate dye-
dependent peak resolution during melting curve analysis. Quan-
titative real-time PCR was conducted in a Lightcycler
TM 1.0
instrument (Roche, Basel, Switzerland) in glass capillaries at 20 ml
volume containing 16 Premix Ex TaqTM (Takara Bio Europe,
France) with either 0.56 SybrGreen I (from 100006 stock),
2.5 mM Syto-13 (from 5 mM stock) or 0.26EvaGreen (from 206
stock) and optimally titrated (with respect to equal melting peak
area) final primer concentrations in the PCR reactions as indicated
in Table 2. PCR cycling was conducted with an initial
denaturation at 95uC for 1 min, 35 cycles with 95uC 10 s/60uC
30 s/72uC 30 s, and final cooling to 40uC for 1 min. A melting
curve was run after cycling by an initial ramping from 40uCt o
70uCa t2 uC/s and a subsequent higher resolution melting
program from 70uCt o9 5 uC at 0.1uC/s. The raw fluorescence
melting curve data (temperature versus fluorescence) was exported
from the Lightcycler v3.5 software. To extend applicability of our
method from a capillary-based real-time PCR system to a block-
based (96-well) system, PCR reactions with setups similar to above
but in 25 ml volume were conducted on a Stratagene Mx3000P
PCR instrument (Agilent Technologies, Palo Alto, CA, USA) and
the melting data exported by the accompanying software.
Melting curve analysis, automatic peak detection and Tm
identification
Exported raw fluorescence melting curve data was imported
into the ‘qpcR’ package [40] for the open-source statistical
environment R (www.r-project.org). The function meltcurve, which
provides automatic raw fluorescence data smoothing, first
derivative calculation and automatic peak detection with Tm
identification, was used to analyze the raw melt data and identify
present or absent amplicons in control and AZF samples. All
melting curves in this work were made by the corresponding plot
parameter of this function.
Validation of amplicons by microcapillary electrophoresis
To verify the validity of the multiplex amplicons, PCR reactions
were size-separated after cycling on an Agilent Bioanalyzer (Model
2100; Agilent Technologies, Palo Alto, CA, USA) using the DNA
1000 capillary chip and checked for their absence in AZF deleted
samples.
Supporting Information
Figure S1 Robustness and sensitivity analysis of the two
multiplex setups. (A) The two different multiplex setups were
tested on four different genomic DNAs from patients without AZF
deletions. Independent of DNA origin, the melting curves display a
highly similar pattern. (B) Microelectrophoretic (Bioanalyzer)
separation of the amplicons obtained in (A). (C) Testing of the
two multiplex setups on a positive control (no AZF deletion) on six
2-fold dilutions. The DNA concentrations are given in the legend
on the right side. Robust melting patterns were obtained with
DNA concentrations higher than 0.35 ng/ml.
(TIF)
Figure S2 Test of new AMELxy/AMELy control primers
for gender specificity and evaluation of the two multi-
plex setups on a block-based (96-well) quantitative PCR
system (Stratagene 3000). (A) Female genomic DNA extracted
from blood was subjected to quantitative PCR using the AMELxy
and AMELy (alternative) primer pairs included in the multiplex
setups. As expected, AMELxy gave a positive signal due to
homology with the AMELx gene, while AMELy was negative. (B)
and (C) Evaluation of the SRY and AMELxy multiplex setup on a
96-well quantitative PCR system (Stratagene 3000), respectively.
Each of the setups was tested on three positive controls (genomic
DNA from men without YCMD, upper row), samples from men
with AZFa, AZFbc and AZFc-deletions (middle row) and negative
control (lower row).
(TIF)
Figure S3 Test for robustness of Setup 1 by using a
second set of control (n=11), AZFc (n=6) and AZFbc
(n=1) samples (Lightcycler 1.0). Setup 1 was tested on an
independent set of control (Con_01–Con_11), AZFc (AZFc_01–
AZFc_06) and AZFbc (AZFbc_01) samples by a different female
scientist. Melting curves of control samples displayed clear
visibility of four peaks. Correspondingly, AZFc and AZFbc
samples exhibited three or two peaks, respectively. Bottom right:
Boxplot from the melting points (Tm values) of all amplicons.
(TIF)
Figure S4 Test for robustness of Setup 2 by using a
second set of control (n=11), AZFc (n=6) and AZFbc
(n=1) samples (Lightcycler 1.0). Setup 2 was tested on an
Real-Time Multiplex PCR for YCMD
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AZFc_06) and AZFbc (AZFbc_01) samples by a different female
scientist. Melting curves of control samples displayed clear
visibility of four peaks. Correspondingly, AZFc and AZFbc
samples exhibited three or two peaks, respectively. Bottom right:
Boxplot from the melting points (Tm values) of all amplicons.
(TIF)
Figure S5 Test for robustness of Setup 3 by using a
second set of control (n=11), AZFc (n=6) and AZFbc
(n=1) samples (Lightcycler 1.0). Setup 3 (Setup 2 with
alternative AMELy primer) was tested on an independent set of
control (Con_01–Con_11), AZFc (AZFc_01–AZFc_06) and
AZFbc (AZFbc_01) samples by a different female scientist. Melting
curves of control samples displayed clear visibility of four peaks.
Correspondingly, AZFc and AZFbc samples exhibited three or
two peaks, respectively. With the exception of one run (Con_03),
all melting peaks could be easily distinguished. Bottom right:
Boxplot from the melting points (Tm values) of all amplicons.
(TIF)
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